Tricida to Report Second Quarter Financial Results and Host Conference Call and Webcast on Monday, August 8, 2022
August 01, 2022 10:00 ET
|
Tricida, Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its second quarter 2022 financial results after the close of market on...
Tricida Announces Administrative Stop of the VALOR-CKD Trial
May 19, 2022 08:30 ET
|
Tricida, Inc.
SOUTH SAN FRANCISCO, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) announced today that as anticipated it is stopping its VALOR-CKD renal outcomes trial early for...
Tricida Announces First Quarter 2022 Financial Results
May 10, 2022 16:05 ET
|
Tricida, Inc.
SOUTH SAN FRANCISCO, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) announced today financial results for the three months ended March 31, 2022 and provided an update on key...
Tricida to Report First Quarter Financial Results and Host Conference Call and Webcast on Tuesday, May 10, 2022
May 03, 2022 10:00 ET
|
Tricida, Inc.
SOUTH SAN FRANCISCO, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its first quarter 2022 financial results after the close of market on...
Tricida to Present at the Needham Virtual Healthcare Conference
April 01, 2022 10:00 ET
|
Tricida, Inc.
SOUTH SAN FRANCISCO, Calif., April 01, 2022 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) announced today that it will present at the 21st Annual Needham Virtual Healthcare Conference on Monday,...
Tricida Announces Fourth Quarter and Full Year 2021 Financial Results
March 29, 2022 16:05 ET
|
Tricida, Inc.
Webcast Today at 4:30 pm Eastern Time SOUTH SAN FRANCISCO, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) announced today financial results for the three months and year...
Tricida to Report Fourth Quarter Financial Results and Host Conference Call and Webcast on Tuesday, March 29, 2022
March 16, 2022 10:00 ET
|
Tricida, Inc.
SOUTH SAN FRANCISCO, Calif., March 16, 2022 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its fourth quarter and year-end 2021 financial results after the...
Tricida Provides Update on Timing of Top-Line Data for the VALOR-CKD Trial Based on Conflict in Ukraine
March 02, 2022 16:26 ET
|
Tricida, Inc.
SOUTH SAN FRANCISCO, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug...
Tricida to Participate in Cowen 42nd Annual Health Care Conference
March 01, 2022 13:30 ET
|
Tricida, Inc.
SOUTH SAN FRANCISCO, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug...
Tricida to Present at the 40th Annual J.P. Morgan Healthcare Conference and the H.C. Wainwright BIOCONNECT Virtual Conference
January 04, 2022 10:00 ET
|
Tricida, Inc.
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the 40th Annual J.P. Morgan Healthcare Conference on Thursday,...